Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular profiling reveals low- and high-grade forms of primary melanoma.
Harbst K, Staaf J, Lauss M, Karlsson A, Måsbäck A, Johansson I, Bendahl PO, Vallon-Christersson J, Törngren T, Ekedahl H, Geisler J, Höglund M, Ringnér M, Lundgren L, Jirström K, Olsson H, Ingvar C, Borg Å, Tsao H, Jönsson G. Harbst K, et al. Among authors: jirstrom k. Clin Cancer Res. 2012 Aug 1;18(15):4026-36. doi: 10.1158/1078-0432.CCR-12-0343. Epub 2012 Jun 6. Clin Cancer Res. 2012. PMID: 22675174 Free PMC article.
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén L, Jirström K, Bendahl PO, Fernö M, Nordenskjöld B, Stål O, Thorstenson S, Jönsson PE, Landberg G. Rydén L, et al. Among authors: jirstrom k. J Clin Oncol. 2005 Jul 20;23(21):4695-704. doi: 10.1200/JCO.2005.08.126. J Clin Oncol. 2005. PMID: 16034044 Clinical Trial.
Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.
Rydén L, Jirström K, Haglund M, Stål O, Fernö M. Rydén L, et al. Among authors: jirstrom k. Breast Cancer Res Treat. 2010 Apr;120(2):491-8. doi: 10.1007/s10549-010-0758-6. Epub 2010 Feb 5. Breast Cancer Res Treat. 2010. PMID: 20135347 Clinical Trial.
PKCalpha expression is a marker for breast cancer aggressiveness.
Lønne GK, Cornmark L, Zahirovic IO, Landberg G, Jirström K, Larsson C. Lønne GK, et al. Among authors: jirstrom k. Mol Cancer. 2010 Apr 14;9:76. doi: 10.1186/1476-4598-9-76. Mol Cancer. 2010. PMID: 20398285 Free PMC article.
319 results